Skip to main content

Jean Coutu’s management team must find ways to expand beyond its Quebec base.

Christinne Muschi/The Globe and Mail

For Jean Coutu Group (PJC) Inc., the prescription is "Deploy major corporate strategy plan. Urgently."

A tough retail sector is getting even tougher as U.S. giants such as Target Corp. and Wal-Mart Stores Inc. set up shop or expand operations in Canada, including selling groceries and drugs.

Pharmacy chains are under pressure to consolidate amid thinning profit margins.

Story continues below advertisement

Loblaw Cos. Ltd. is taking over Shoppers Drug Mart in a $12.4-billion deal that will accelerate the blurring of the lines between drugs, grocery, fashion and merchandise retailing, as well as creating a major challenger to Coutu's market dominance in Quebec.

Coutu's management team must find ways to expand beyond its Quebec base and better position itself to successfully fight rising competition in the quickly shifting retail landscape.

The Longueuil, Que.-based chain happens to be sitting on a pile of cash of about $460-million, with the resources to spend more than $1-billion on everything from a share buyback or a special dividend to a significant takeover of another, smaller chain.

So far, president and chief executive officer François Coutu has been tight-lipped about what the company plans to do. Investors hope he opens up on Wednesday, when Coutu releases its second-quarter results and Mr. Coutu and senior executives hold a conference call.

Among potential takeover targets are the Rexall pharmacy banner owned by closely held Edmonton-based Katz Group Canada Ltd.; Lawtons Drugs, part of Stellarton, N.S.-based Sobeys Inc.'s portfolio; and any Shoppers stores that may come up for sale in the merger with Loblaw.

Coutu is spending $190-million to build a new head office and distribution centre, suggesting it is preparing for further expansion. "We still want to grow a number of stores, we still want to grow the possibilities, not only in this province but elsewhere," Mr. Coutu said on his previous conference call.

But there is also much speculation that Montreal-based Metro Inc. would love to emulate Loblaws-Shoppers by doing a similar deal with Coutu.

Story continues below advertisement

Analyst Derek Dley of Canaccord Genuity said in a recent research note looking ahead to the second quarter: "We will be looking for increased clarity on Jean Coutu's plans to deploy its sizeable cash balance of approximately $2 per share, following the recent sale of its entire remaining interest in Rite Aid, for proceeds of roughly $192-million."

Mr. Dley forecasts second-quarter earnings before interest, taxes, depreciation and amortization (EBITDA) of $86-million, up from $77-million in the year-earlier period, and earnings per share of 26 cents, compared with 23 cents and slightly above the analysts' consensus of 25 cents.

Report an error Editorial code of conduct
Tickers mentioned in this story
Unchecking box will stop auto data updates
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies